Literature DB >> 166991

Hydrophobic binding sites on human interferon.

M W Davey, J W Huang, E Sulkowski, W A Carter.   

Abstract

Human interferon binds to a omega-carboxpentyl-agarose column at low ionic strength (0.15 M NaCl) and is still retained when the ionic strength is raised (to 1.0 M NaCl). The binding can be reversed, however, by ethylene glycol, indicating a hydrophobic interaction. The binding of human interferon to omega-aminohexyl-agarose is weak, even at a low ionic strength, and is probably exclusively electrostatic. This disparate binding behavior may be caused by the presence of a positive charge, adjacent to the hydrophobic binding site, on human interferon. The interaction of human interferon with omega-carboxypentyl-agarose is quite selective, inasmuch as the majority of proteins present in interferon preparations pass through the column unretained. Hydrophobic chromatography of human interferon may thus be useful in its purification.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 166991

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Inhibition of murine L cell interferon action by heparin.

Authors:  A Sakai; T Ebina; N Ishida
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  Purification and characterization of mouse interferon with novel affinity sorbents.

Authors:  M W Davey; E Sulkowski; W A Carter
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

3.  Glycosylation of human leukocyte interferon: effects of tunicamycin.

Authors:  K C Chadha; P M Grob; R L Hamill; E Sulkowski
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

4.  Affinity chromatography of primary human amnion interferon.

Authors:  P C Ferreira; M Paucker; R R Golgher; K Paucker
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

5.  Molecular structure of human fibroblast and leukocyte interferons: probe by lectin and hydrophobic chromatography.

Authors:  W J Jankowski; M W Davey; J A O'Malley; E Sulkowski; W A Carter
Journal:  J Virol       Date:  1975-11       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.